Kyrgyzstan vs North America: Prevalence of hypertension, female
Kyrgyzstan
43.2%
in 2019
North America
28.0%
in 2019
Kyrgyzstan rank
34th
North America rank
37th
Prevalence of hypertension, female over time
- Kyrgyzstan
- North America
How they compare
Kyrgyzstan currently reports 43.2% against 28.0% in North America, a difference of 15.2%.
That makes Kyrgyzstan's figure about 1.5 times North America's.
Across all 30 years both countries report, Kyrgyzstan has been ahead every year.
Kyrgyzstan ranks 34th and North America ranks 37th of 192 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | North America | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.8% | 28.8% | 11.1% | Kyrgyzstan |
| 2000s | 41.0% | 29.3% | 11.7% | Kyrgyzstan |
| 2010s | 42.8% | 28.6% | 14.2% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, female, Kyrgyzstan or North America?
- Kyrgyzstan, at 43.2% against 28.0% in North America as of 2019.
- What is the difference in prevalence of hypertension, female between Kyrgyzstan and North America?
- 15.2%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and North America?
- 30 years are reported by both, from 1990 to 2019.
- How do Kyrgyzstan and North America rank globally for prevalence of hypertension, female?
- Kyrgyzstan ranks 34th and North America ranks 37th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.